On Jul. 31, 2020, Quidel announced a preliminary contract with the NIH to support the expansion of its…
On Jul. 31, 2020, Sanofi and GSK announced advanced discussions, with the European Commission for the supply of…
On Jul. 31, 2020, researchers from the Pacific Northwest National Laboratory (PNNL) and Oregon Health & Science University…
On Jul. 31, 2020, OraSure Technologies announced that its OMNIgene-ORAL (OM-505) saliva collection device is included in the…
On Jul. 30, 2020, RedHill Biopharma announced that it has initiated a global Phase 2/3 clinical study evaluating…
On Jul. 30, 2020, Precipio announced it had entered into an agreement with ADS Biotec, based in Omaha,…
On Jul. 30, 2020, Seqirus announced it had begun shipping its portfolio of seasonal influenza vaccines to customers…
On Jul. 30, 2020, INOVIO announced that its COVID-19 DNA vaccine INO-4800 targeting SARS-CoV-2 was effective in protecting…
On Jul. 29, 2020, the Encyclopedia of DNA Elements (ENCODE) Project is a worldwide effort to understand how…
On Jul. 29, 2020, Regeneron announced that the Biomedical Advanced Research and Development Authority (BARDA) had entered into…
On Jul. 29, 2020, Sanofi and GSK announced an agreement with the UK government for the supply of…
On Jul. 28, 2020, Gilead Sciences and the Satcher Health Leadership Institute at Morehouse School of Medicine announced…
On Jul. 28, 2020, Moderna announced a preclinical study evaluating mRNA-1273, its vaccine candidate against COVID-19, was published…
On Jul. 28, 2020, Soligenix announced publication of pre-clinical immunogenicity studies for its CiVax program (heat stable COVID-19…
On Jul. 28, 2020, Soligenix announced publication of pre-clinical immunogenicity studies for its CiVax™ program (heat stable COVID-19…
On Jul. 27, 2020, FUJIFILM Diosynth Biotechnologies (FDB) and Texas A&M announced they mass will produce vaccines as…
On Jul. 27, 2020, the National Institutes of Health (NIH) announced that a phase 3 clinical trial designed…
On Jul. 27, 2020, Amyris and the Infectious Disease Research Institute (IDRI) announced the signing of a binding…
On Jul. 27, 2020, MediciNova announced an agreement with BioComo and Mie University (Mie prefecture, Japan) for joint…
On Jul. 27, 2020, Humanigen announced that the National Institute of Allergy and Infectious Diseases and Humanigen had…
On Jul. 27, 2020, Moderna announced that the Phase 3 study of its mRNA vaccine candidate (mRNA-1273) against…
On Jul. 27, 2020, Onconova Therapeutics announced that it had submitted an application with the National Institute of…
On Jul. 26, 2020, Moderna announced a modification to its contract with the Biomedical Advanced Research and Development…
On Jul. 24, 2020, the governing Board of the California Institute for Regenerative Medicine (CIRM) approved two new…
On Jul. 23, 2020, Dynavax Technologies and Medigen Vaccine Biologics announced their collaboration to develop an adjuvanted vaccine…
On Jul. 23, 2020, Novavax and FUJIFILM Diosynth Biotechnologies announced an agreement to manufacture bulk drug substance for…
On Jul. 23, 2020, AXIM Biotechnologies announced development of NeuCovixTM, a rapid diagnostic test measuring levels of functional…
On Jul. 23, 2020, Dynavax Technologies and Medigen Vaccine Biologics (MVC) announced a collaboration to develop an adjuvanted…
On Jul. 22, 2020, RedHill Biopharma announced that it had submitted a Clinical Trial Application (CTA) with the…
On Jul. 22, 2020, through the Canadian COVID Genomics Network (CanCOGeN) ‘a new initiative was launched by Genome…